HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sampsa Hautaniemi Selected Research

Neoplasm Metastasis (Metastasis)

1/2018Dynamic visualization of multi-level molecular data: The Director package in R.
5/2015MMP16 Mediates a Proteolytic Switch to Promote Cell-Cell Adhesion, Collagen Alignment, and Lymphatic Invasion in Melanoma.
12/2012An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sampsa Hautaniemi Research Topics

Disease

41Neoplasms (Cancer)
01/2022 - 01/2004
19Breast Neoplasms (Breast Cancer)
02/2018 - 11/2002
14Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 08/2015
8Prostatic Neoplasms (Prostate Cancer)
03/2013 - 05/2004
6Glioblastoma (Glioblastoma Multiforme)
06/2013 - 09/2010
5Genomic Instability
08/2020 - 04/2009
4Adenocarcinoma
01/2022 - 01/2013
3Disease Progression
11/2021 - 01/2017
3Melanoma (Melanoma, Malignant)
03/2021 - 12/2012
3Carcinogenesis
11/2018 - 08/2011
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 03/2011
3Neoplasm Metastasis (Metastasis)
01/2018 - 12/2012
2Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 10/2011
2Carcinoma (Carcinomatosis)
01/2022 - 01/2021
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2017 - 04/2011
2Hypersensitivity (Allergy)
05/2014 - 06/2010
2Milk Hypersensitivity (Milk Allergy)
05/2014 - 06/2010
2Glioma (Gliomas)
02/2013 - 01/2013
2Lymphoma (Lymphomas)
05/2010 - 10/2006
2Infections
11/2009 - 03/2005
1Plague (Bubonic Plague)
01/2022
1Ascites
01/2020
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2019
1Ductal Carcinoma
02/2018
1Androgen-Insensitivity Syndrome (Testicular Feminization)
01/2016
1Triple Negative Breast Neoplasms
04/2015
1Inflammation (Inflammations)
11/2014
1Mycoses (Diseases, Fungus)
06/2014
1Neuralgia (Stump Neuralgia)
06/2014
1Wounds and Injuries (Trauma)
06/2014

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2016 - 03/2005
8Pharmaceutical PreparationsIBA
11/2021 - 03/2011
6RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
6MicroRNAs (MicroRNA)IBA
02/2018 - 01/2013
5Messenger RNA (mRNA)IBA
02/2018 - 11/2002
5DNA (Deoxyribonucleic Acid)IBA
03/2015 - 11/2002
4PlatinumIBA
01/2021 - 08/2015
4Complementary DNA (cDNA)IBA
09/2004 - 11/2002
3Drug CombinationsIBA
11/2021 - 01/2018
3Transcription Factors (Transcription Factor)IBA
02/2018 - 01/2013
3CathepsinsIBA
02/2018 - 03/2005
3Calcibiotic Root Canal SealerIBA
01/2018 - 03/2011
3Estrogen ReceptorsIBA
01/2016 - 01/2013
3Small Interfering RNA (siRNA)IBA
02/2013 - 03/2005
3Rituximab (Mabthera)FDA Link
04/2011 - 10/2006
2NucleotidesIBA
08/2020 - 10/2019
2Mitochondrial DNA (mtDNA)IBA
08/2020 - 10/2019
2Indicators and Reagents (Reagents)IBA
01/2020 - 05/2015
2Biomarkers (Surrogate Marker)IBA
01/2020 - 12/2019
2taxaneIBA
12/2019 - 08/2015
2Circulating Tumor DNAIBA
12/2019 - 01/2019
2MucinsIBA
11/2018 - 01/2017
2ZincIBA
02/2018 - 03/2012
2Phenobarbital (Luminal)FDA Link
01/2017 - 04/2009
2Paclitaxel (Taxol)FDA LinkGeneric
03/2016 - 03/2011
2prostatic acid phosphataseIBA
02/2016 - 01/2013
2Androgen Receptors (Androgen Receptor)IBA
01/2016 - 09/2011
2ChromatinIBA
11/2015 - 09/2011
2Membrane Proteins (Integral Membrane Proteins)IBA
05/2015 - 12/2012
2Progesterone Receptors (Progesterone Receptor)IBA
04/2015 - 08/2011
2Immunoglobulin E (IgE)IBA
05/2014 - 06/2010
2EpitopesIBA
05/2014 - 06/2010
2Immunoglobulin G (IgG)IBA
05/2014 - 06/2010
2Genetic Markers (Genetic Marker)IBA
05/2013 - 01/2013
2AndrogensIBA
03/2013 - 09/2011
2ProteomeIBA
10/2011 - 03/2005
2OligonucleotidesIBA
10/2006 - 06/2004
1Therapeutic UsesIBA
11/2021
1Oncogene Proteins (Oncogene Protein)IBA
11/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2020
1niraparibIBA
01/2020
1pembrolizumabIBA
01/2020
1Aurora KinasesIBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2019
1anagrelide (Agrylin)FDA LinkGeneric
01/2019
1AntigensIBA
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Guanosine Diphosphate Mannose (GDP Mannose)IBA
11/2018
1Polysaccharides (Glycans)IBA
11/2018
1Metalloproteases (Metalloproteinases)IBA
01/2018
1Mitogen-Activated Protein KinasesIBA
12/2017
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2017
1LipidsIBA
01/2016
1Cell Adhesion MoleculesIBA
05/2015
1CollagenIBA
05/2015
1Membrane-Associated Matrix MetalloproteinasesIBA
05/2015
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
05/2015
1CytokinesIBA
11/2014
1Analgesics (Analgesic Drugs)IBA
06/2014
1Adenosine (Adenocard)FDA LinkGeneric
06/2014
1thiamine monophosphataseIBA
06/2014
1Netrin-1IBA
06/2013

Therapy/Procedure

13Therapeutics
11/2021 - 01/2004
8Drug Therapy (Chemotherapy)
01/2022 - 10/2006
1Neoadjuvant Therapy
01/2020
1Aftercare (After-Treatment)
01/2019
1Adjuvant Chemotherapy
01/2017
1Immunotherapy
05/2014
1Castration
03/2013